Tekmira Pharmaceuticals Completes ApoB SNALP Phase 1 Clinical Trial

Friday, January 8th, 2010

Tekmira Pharmaceuticals Corporation (TSX:TKM) announced that it has concluded its ApoB SNALP Phase 1 human clinical trial. ApoB SNALP is designed to reduce the production of apolipoprotein B (ApoB), a protein produced in the liver that plays a central role in cholesterol metabolism. Tekmira enrolled a ...

Posted in Healthy LifeStyle | No Comments »

Synexus Leads The Way In South Africa With Vital Paediatric Vaccines Trial

Tuesday, November 24th, 2009

UK-based Synexus, the world's largest multi-national company dedicated to the recruitment and running of clinical trials, recruited the highest number of patients to the South African study investigating a paediatric vaccine against rotavirus. The company recruited more than 2000 children aged between 5 and 10 weeks in ...

Posted in Healthy LifeStyle | No Comments »